Correlation Between Gilead Sciences and Oramed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Oramed Pharmaceuticals, you can compare the effects of market volatilities on Gilead Sciences and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Oramed Pharmaceuticals.
Diversification Opportunities for Gilead Sciences and Oramed Pharmaceuticals
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gilead and Oramed is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Oramed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Gilead Sciences and Oramed Pharmaceuticals
Given the investment horizon of 90 days Gilead Sciences is expected to generate 2.0 times less return on investment than Oramed Pharmaceuticals. But when comparing it to its historical volatility, Gilead Sciences is 2.35 times less risky than Oramed Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Oramed Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 183.00 in Oramed Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 51.00 from holding Oramed Pharmaceuticals or generate 27.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Oramed Pharmaceuticals
Performance |
| Timeline |
| Gilead Sciences |
| Oramed Pharmaceuticals |
Gilead Sciences and Oramed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Oramed Pharmaceuticals
The main advantage of trading using opposite Gilead Sciences and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.| Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
| Oramed Pharmaceuticals vs. Capricor Therapeutics | Oramed Pharmaceuticals vs. Akari Therapeutics PLC | Oramed Pharmaceuticals vs. Soleno Therapeutics | Oramed Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |